Balyasny Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18M | Sell |
1,777,744
-229,528
| -11% | -$2.33M | 0.03% | 532 |
|
|
2025
Q1 | $11.2M | Buy |
2,007,272
+452,012
| +29% | +$2.52M | 0.02% | 616 |
|
|
2024
Q4 | $12.6M | Buy |
1,555,260
+424,194
| +38% | +$3.42M | 0.02% | 624 |
|
|
2024
Q3 | $11.6M | Buy |
+1,131,066
| New | +$11.6M | 0.02% | 615 |
|
|
2023
Q2 | – | Sell |
-11,725
| Closed | -$66.8K | – | 2180 |
|
|
2023
Q1 | $66.8K | Buy |
+11,725
| New | +$66.8K | ﹤0.01% | 1917 |
|
|
2022
Q4 | – | Sell |
-13,557
| Closed | -$43K | – | 2629 |
|
|
2022
Q3 | $43K | Buy |
+13,557
| New | +$43K | ﹤0.01% | 2005 |
|